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1.0  INTRODUCTION 
 
1.1   HEART FAILURE 
Heart failure (HF) is a chronic disease with debilitating consequences which has become a 
threat to the global health care system. The American Heart Assosiation (AHA) reported the 
prevalence of HF in its population as 2.6% as of 2006 with more than 200,000 deaths linked 
to it. Following improved standard of living  and increasing  aging population, this entity has 
risen dramatically in the developed countries. Approximately 550,000 people are diagnosed 
with HF annually in the United State and this number is expected to rise to 1.5 million by 
2040   (Asrar, Goy, Levinger, Wong & Hare, 2015). It is estimated that about 17 – 45% of 
patients admitted in the hospital with HF do not survive beyond one year post-admission 
while majority die within 5 years of admission. However, the survival rate for HF have 
increased in most parts of the world and this has been attributed to the improvement in 
medical care and evidenced-based treatment methods (Ponikowski et al. 2014). In the UK, in-
hospital mortality has fallen from 11.1% in 2011 to 9.4% in 2013; which corresponds to a 
relative and absolute reduction of 15.3% and 1.7% respectively. In addition, mortality for 
those admitted in the hospital with HF who survive until discharge has also reduced 
significantly from the year 2011 to 2013 (National Heart Failure Audit (NHFA), 2012). 
Although significant progress has been made, yet about 2 – 17% of patients admitted to the 
hospital with HF die during hospitalisation while those who have less symptoms and are 
treated on out-patient’s basis seem to have better prognosis. The basis for this disparity still 
remains unclear and the best therapeutic intervention so far offered to HF patients only 
provide symptomatic relieve but no real change in terms of modifying disease progression or 
final outcome. Despite obvious improvement in care over the past 20 years, HF has remained 
a threat to public health and its poor survival rate makes it even worse than breast, bowel or 
even prostate cancer. Nearly 26 million people are living with HF prompting some to refer to 
it as a global pandemic. In North America and Europe, less than 20% of the patients with HF 
are 50 years or under whereas more than 80% of them are 65year or above; and the number is 
thought to be on the increase in countries with ageing population (Ponikowski et al. 2014).  
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Exercise training (ET) has been well established as an adjunct therapy in the management of 
HF. Prior to three decades ago, exercise was prohibited for HF patients while bed rest was 
rather recommended. However, this line of thought has since been challenged and the first 
evidence was published  in 1990 arguing in favour of exercise training which showed that 
exercise tolerance and HF symptoms improved following exercise without any adverse 
outcome (Asrar Ul Haq, Goy, Levinger, Wong & Hare, 2015). 
 
The aim of this review therefore is to examine: 
 
(1) The basic clinical science about the heart and circulation 
(2) Heart failure: causes and management  
(3) Different modes of exercise before proceeding to its benefits in terms of correction of 
endothelial dysfunction in these group of patients. 
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2.0 CARDIAC ANATOMY 
 
2.1  LAYERS OF THE HEART WALL 
The wall of the heart is made up of three layers: epicardium, the myocardium and the 
endocardium. The epicardium is the outer most part of the heart and is synnonymous with the 
serous pericardium and can become fatty in the elderly. The middle layer known as the 
myocardium forms the muscular part of the heart. It is the layer that contracts during cardiac 
cycle. Crisscrossing connective tissue fibres link muscles cells to each other in this layer 
forming spiral or circular bundles which connect all the parts of the heart together. These 
connective tissue form a fibrous skeleton for the heart which helps to reinforce the 
myocardial cells providing strenght internally. This connective tissues (collagen and elastic 
fibres) are thicker in some parts of the heart. There absence means that the great vessels and 
valves would be stretched to their maximum and might eventually be worn out due to the 
enormous amount of stress that is exerted on them during each blood cycle. Third layer is the 
endocardium, which is the squamous epithelium lining the inner surface of the heart 
chambers and provides cover to the fibrous skeleton of the heart valves. This endocardium is 
continous with the endothelium of the peripheral vasculature (Marieb & Hoehn, 2010). 
 
2.2   HEART CHAMBERS  
The heart consist of four chambers: two receiving chambers (atria) and two discharging 
chambers (ventricules).  The atria are made up of the auricles and the right and left atria. 
Internally the right atrium has a smooth-walled posterior part and an anterior with irregular 
bundle end known as pectinate muscle. The anterior and posterior parts are demarcted by a 
semi-circular rigde ( crista terminalis). Conversely, the left atrium is mostly smooth and the 
pectinate muscle are located only on the auricle. The interatrial septum has a slight 
depression, the fossa ovalis, which is an embyonic remnant of fetal circulation. The atria are 
thin walled since they do minimal work of pushing the blood down the gradient. Basically, 
blood enters the  right atrium from the coronary sinus, superior and inferior vena cava. While 
the left atrium recieves blood from the four pulmonary veins. 
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The ventricles primarily make up the greater volume of the heart. The right ventricle form the 
major part of the anterior surface of the heart whereas the left ventricle occupies most of the 
posterior and inferior surface. The trabeculae carnea mark the internal surface of the 
ventricles with the papillary muscles which play a vital role in valve closure during systole. 
The ventricles are responsible for pumping blood out of the heart, as a result, their walls are 
thicker in size.  The right ventricle pumps blood into the pulmonary bed where gaseous 
exchange takes place while the left ventricles pump blood directly through the aorta into the 
systemic circulation( Marieb & Hoehn, 2010). 
 
 
2.3  CARDIAC FUNCTION 
Research has shown that heart functions are directly linked to the atrial pressures. This 
pressure can be plotted as an independent variable against other markers of cardiac function. 
Four types of function curves have been use in describing cardiac function but the  curve 
relating cardiac output to mean right atrial pressure appears most useful in describing heart 
function. This curve indicate a significant rise in cardiac output with a slight increase in right 
atrial pressure. This perculiarity in essense, is as a result of stretch on the cardiac muscle 
fibre. As the end diastolic pressure increases, the ventricular volume expands, lengthening the 
cardiac muscle fibres. Following this, the force of contraction of the fibres increases, giving 
rise to enormous amount of pumping ability in the ventricules. This effect was described 
nearly hundred years ago by starling and his colleagues and is known as starling’s law of the 
heart.  
This intrinsic ability of the heart enables it to double its output with a single contraction when 
the end diastolic contraction is raise by 1 or 2 mmHg. However, the heart reaches its elastic 
limit when the fibre are stretch to a maximum. The mean ventricular end diastolic pressure at 
which the cardiac output flattens out on the curve is the filling pressure  that yields the 
greatest amount of force from the ventricules. Systemic resistance and arterial pressure 
affects the cardiac function curve. If the resistive load is held at a constant then arterial 
pressure will gradually increase as cardiac output increase; as a result the pumping ability of 
the left ventricule will be reduced as more force required to overcome the ongoing resistance 
(Young, 2010). 
 
3.0  VASCULAR ANATOMY & PHYSIOLOGY 
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In terms of function, the tunica intima together with the vascular endothelium and the tuinca 
media (which contains smooth-muscle cells) make up the blood vessels. They are linked in 
specific ways to maintain the vascular tone.Blood vessel tone is controlled centrally with the 
sympathetic and parasympathetic nervous system. Equally, endocrine actions also occur. 
When neural component is damaged, for example, in pathological state, then the endocrine 
control of blood vessels mediates using adrenaline, angiotensin or vasopressin. In the event of 
arterial blood pressure instability, blood vessels vasoconstrict independently of nervous input 
when blood pressure drops and vice versa. This process of autoregulation is a direct result of 
the blood vessels’ ability to constrict when distended (bayliss myogenic response) and that 
caused by reduced amount of tissue metabolite (vasodilator washout). The vascular 
endothelium is a cardiovascular endocrine organ, and interfaces between blood and other 
tisues. It produces various compounds as listed below :  
 
Table 1.  MAJOR ENDOTHELIAL PRODUCTS AND FUNCTIONS       
                  
Endothelial product       Function(s)      stimulus 
Nitric oxide    Vasodilatation 
  Inhibits platelet aggregation 
  Inhibits transcription of adhesion   
  Molecules 
  Inhibits vascular smooth muscle  
  proliferation 
Shear stress, e.g. induced by exercise 
Agonists: thrombin, acetylcholine, 
Endothelin, bradykinin, serotonin, 
substance P, inflammation/endotoxin 
shock 
Prostacyclin (PG1)   Vasodilatation 
   Inhibits platelet aggregation 
Agonist: thrombin inflammation 
Prostanoids    Vasoconstriction hypoxia 
Endothelin   Vasoconstriction  Thrombin, angiotensin II, vasopressin 
 Hypoxia 
Note: inhibited by shear stress 
Endothelial-derived  
Hyperpolarizing factor 
  Vasodilatation Agonist: bradykinin, acetylcholine 
Angiotensin-
converting  enzyme  
   Vasoconstriction Expressed naturally 
Von willebrand factor     Promotes platelet aggregation  
    Stabilizes factor VIII  
Agonist: thrombin, epinephrine 
Adhesion molecules 
P,L,E selectins 
ICAM, VCAM, PECAM 
 
    Marginating of white blood cells  
    Binding and diapedesis of WBCs into  
    Vessel wall 
Inflammatory mediators: histamine, 
thrombin, TNF, IL-6 
                                                                       
Vascular endothelial 
growth factor (VEGF) 
 
   Angiogenesis 
   Vasodilatation 
    Increased vascular permeability  
 
Pregnancy 
Hypoxia 
Inflammation, e.g. rheumatoid 
arthritis 
Trauma 
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ICAM, intracellular adhesion molecule; VCAM, vascular cell adhesion molecule, PECAM,    
platelet/endothelial cell adhesion molecule; TNF, tumour necrosis factor; IL, interleukin                                                                                                                                      
 
                                                                                   (kumar & Clark, 2012) 
  
 
4.0 HEART FAILURE 
 
4.1 DEFINITION 
Heart failure(HF) is a complex clinical syndrome of signs and symptoms suggesting an 
impairment in the ability of the heart to function as a pump to support the circulatory system. 
It is often as a result of structural or functional abnormalities in the heart (NICE, 2010). This 
condition affects approximately 5.7 million people globally and those with HF experiences 
great reduction in the quality of their life in addition to frequent hospital admissions. Patients 
with HF presents with different symptoms, some of which develop insidiously over many 
days whereas in other circumstance, it could develop almost simultaneoulsy. Some of the 
symptoms include dyspneoa, pedal oedema, fatigue, dyspnoea on exertion, orthopnoea, 
paroxysmal nocturnal dyspneoa, cough, nausea, palpitations and weight gain (Gallagher et al. 
2012).  
 
4.2  Etiology 
NHFA (2012), has listed the following conditions as the major causes of HF: hypertension 
(54%), ischemic heart disease (IHD) (46%), myocardial infarction (MI) (31%), valvular heart 
disease (22%), diabetes (31%) and renal impairment (26%). 
 
4.2.1 HYPERTENSION 
Hypertension causes the increase in sympathetic tone which subsequently causes peripheral 
vasoconstriction and the release of noradrenaline from the adrenal glands. Renal blood flow 
is impaired due to activation of the renal efferent sympathetics. The renal sympathetic 
nervous system causes the reabsorption of sodium ions with release of renin. This  triggers 
the renin-angiotensin-aldosterone pathway (RAAS) and further constrict the vessels leading 
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to severe damage (Elliott, Bakris & Black, 2004). The total peripheral resistance is increased 
in hypertensive state, thus leading to increase afterload and the left ventricle often 
compensate by forming a concentric hypertrophy but this is short lived and the heart will 
eventually fails (Beevers, Lip & O’Brien, 2007).  
 
4.2.2 ISCHEMIC HEART DISEASE (IHD) 
This is caused by the deposition of lipid molecules on the endothelium of the vessels thereby 
narrowing the lumen and altering its function. This condition usually deprives the 
myocardium the required amount of oxygen and nutrients. Prolonged reduction in the 
coronary blood flow will result in regional necrosis of the affected part leading to ventricular 
failure (Digirolamo and Schlant, 1978). 
 
4.2.3 MYOCARDIAL INFARCTION (MI) 
Infarction of the myocardium ensues when an emboli occludes an artery supplying the heart 
wall with a resultant necrosis of the affected part (Robbins, Cotran & Kumar, 1984). As a 
result more work is expected from the unaffected myocardium during systole in other to meet 
up with systemic output (Khan, 2006).  In the affected part there is loss of myocardial cell 
function, myocardial fibrosis, and left ventricular (LV) remodelling. Following this, the LV 
enlarges triggering the activation of the RAAS in order to compensate for decrease cardiac 
output but this development further causes the heart to deteriorate (Heart Failure Society of 
America (HFSA), 2010).  
 
4.2.4 VALVULAR DISEASE/ DYSFUNCTION 
 In cardiac valve disease, aortic stenosis raises the resistance in the left ventricle leading to 
increase in pressure afterload which in turn results in left ventricular hypertrophy (concentric 
hypertrophy) as a compensation for the narrowed aortic opening. The end-diastolic pressure 
is increased and LV poor perfusion with LV dysfunction ensues (Khan, 2006). 
 
4.2.5 DIABETES MELLITUS AND RENAL FAILURE 
In diabetes, there is increased risk for endothelial dysfunction which predisposes the 
individual to clot formation and arteriosclerosis development. Studies have shown that high 
blood sugar attenuates the effect of NO (nitric oxide) which is an endothelium derived 
vasodilator while upgrading the activities of vasoconstrictors such as prostanoid and 
endothelin; these molecules in turn lead to increase in peripheral resistance (Creager, 
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Luscher, Cosentino  & Beckman,2003). In addition, hyperinsulinemia has been put forward 
to increase the amount of sodium and water resorption in the distal tubules and this leads to a  
rise in intracellular sodium and calcium ions in vascular smooth muscle cells resulting to 
increased contractile ability on the background of pre-existing raised peripheral resistance 
(TPR)  (Williams & Pick-up, 2004). The ability of the kidneys to excrete waste products is 
impaired in conditions like the renal failure leading to the accumulation of not only 
nitrogenous substance in the body but also sodium and fluid (Tuttle & Hall, 1978).  Renal 
failure accounts for approximately a third of HF in the UK between 2011 and 2012 (NHFA, 
2012).  
 
4.3             CLASSIFICATION AND STAGES OF HEART FAILURE 
According to the New York Heart Association Functional Classification (NYHA): 
 
I.  Patients with cardiac problems which does not result to any limitations of physical activity. 
Ordinary physical activity does not cause undue fatigue, palpitation, dyspnoea or angina pain. 
 
II. Patients with heart problem which is causing slight limitation of physical activity.  But 
they are comfortable at rest. Ordinary physical activity will result in fatigue, palpitation, 
angina pain and dyspnoea. 
 
III. Patients with heart problem which causes marked limitation of physical activity. These 
people are also comfortable at rest. Less than ordinary physical activity causes fatigue, 
palpitation, dyspnoea or angina pain. 
 
IV. Patients with cardiac disease resulting in the inability to carry on any physical activity 
without discomfort. Symptoms of cardiac insufficiency or of the angina syndrome may be 
present even at rest. If any physical activity is undertaken, discomfort is increased (Francis, 
Wilson Tang & Sonnenblick, 2004).  
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4.4 PATHOPHYSIOLOGY 
There are two main forms of HF (HF with preserved ejection fraction; HFPEF and HF with 
reduced ejection fraction; HFREF) (Pearse & Cowie, 2014). HFPEF can be a difficult 
diagnosis to reach, however, epidemiological studies reveal that approximately 50% of HF 
patients have preserved EF. In HFPEF (diastolic heart failure), there is diastolic dysfunction 
leading to concentric hypertrophy as a way of compensating for the condition. This is 
common with hypertensive heart disease and often occur among elderly females. Conversely, 
HFREF (systolic HF) occurs when a disease process has occurred in a part of the 
myocardium (e.g. MI) or the myocardium is generally affected (e.g. dilated cardiomyopathy). 
The outcome is a heart which is filling well during diastole but is unable to contract 
efficiently during systole to eject the required volume of blood. This leads to an increase in 
cardiac size and stretching of the myocardium in accordance with Starling’s law to initially 
increase cardiac output. However, this compensatory mechanism does eventually fail and the 
cardiac output gradually deteriorates with left ventricular enlargement. The end-result of 
either HFPEF or HFREF is a reduction in cardiac output which will lead to poor perfusion of 
organs and subsequently trigger a complex neuro-humoral response (Pearse & Cowie, 2014; 
Nanayakkara & Kaye, 2015).  
 
 
 
4.5 PATHOGENESIS OF SIGNS AND SYMPTOMS 
When the heart fails to pump a sufficient volume of blood as a result of any of the above 
mentioned aetiologies, the kidney usually detect such anomaly as hypo-perfusion and this 
will trigger the activation of the sympathetic system. Adrenaline and nor-adrenaline would be 
released subsequently to act on the myocardium increasing its contractility but the effect is 
short-lived.  The RAAS pathway is simultaneously activated to increase sodium ion and 
water re-absorption which aims to restore the intravascular volume whereas vasoconstriction 
is also induced via angiotensin II to improve venous return. However, these protective 
mechanisms are not sustained for too long and the heart eventually fails (Francis, Wilson 
Tang & Sonnenblick, 2004). According to Khan (2006), when the heart is unable to pump out 
the blood that flows into its chambers this causes stasis of blood in the vessels. The 
pulmonary veins become engorged and water and sodium ion begins to leak out in the 
pulmonary bed causing dyspnoea, orthopnoea and frothy sputum. This also results in hypo-
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perfusion of skeletal muscles worsened by the pre-existing vasoconstriction, patients become 
easily fatigued. The engorged veins continue to leak out fluids in the legs, abdomen and 
further reduces the quality of life, physical activity and exercise tolerance.   
During this condition, there is altered redox state in the vascular bed leading to 
overproduction of reactive oxygen species.  The neuro-humoral pathway is activated, 
myocardium releases inflammatory mediators and alteration of local shear stress lead to 
further production of free oxygen radicals and reduction in nitric oxide (NO). This creates 
imbalance in the functional ability of the blood vessels and the resulting endothelial 
dysfunction triggers the release of cytokines, uncoupling of nitric oxide synthetase (eNOS); 
which further deteriorates the heart and advances the progression in HF (Deanfield, Halcox, 
& Rabelink, 2007). Increase in afterload is noted following rise in systemic and pulmonary 
vascular constriction; vasomotor dysregulation gradually develops in the kidneys and 
together with the endothelial dysfunction in the coronary vessels the heart continues to 
worsen. The endothelium-dependent vasodilatation in the coronary vessels, for example, are 
impaired worsening coronary blood flow and ventricular function. NO imbalances negatively 
affects the matrix metalloproteinase production which alters cell migration, cardiac 
hypertrophy and atherosclerotic plaque instability.  Endothelin-1 rises sharply and this causes 
increased vascular resistance, smooth muscle cell growth, and matrix production leading to 
vascular remodelling, endothelial dysfunction and HF progression. Reduced amount of NO in 
HF affects the endothelial progenitor cells, disabling endothelial repair or regeneration. 
Furthermore, circulating cytokines, for instance the tumour necrosis factor (α-TNF) causes 
the down regulation of eNOS which further damages the heart and blood vessels (Marti et al. 
2012)    
 
 
  
 
 
 5.0 PHARMACOTHERAPY 
 
Although mortality rates from HF are high, a number of pharmacological interventions have 
proven to be beneficial. Angiotensin Converting Enzyme inhibitor (ACEi) and beta-blockers 
reduces mortality and it is recommended for all patients except in cases where they are 
contraindicated (NICE, 2010). For instance, where ACEi are not well tolerated, angiotensin 
21 
 
receptor blockers (ARB) may be used. While individuals with complications such as fluid 
overload are likely to benefit from diuretics, those receiving aldosterone antagonist and 
vasodilators have shown significant reduction in mortality (Chavey et al. 2008). 
 
 5.1 ACEi 
According to NICE clinical guidelines (2010), the (ACEi) is the common drug of choice in 
the management of HF. There are evidence that more than two-third of patients have been 
discharged on ACEi in the UK hospitals between 2011 and 2012 with the figures for men and 
women nearing 85% and 83% respectively (NHFA, 2012). Research has shown that these 
medication competitively blocks the Angiotensin Converting Enzyme (ACE) which is a 
membrane bound enzyme on the vascular endothelium. This subsequently prevents the 
conversion of angiotensin I to angiotensin II, which is a more potent vasoconstrictor 
implicated in the pathogenesis of HF (Richardson, 2007). By this action, they interrupt the 
RAAS pathway which is unusually active in HF. In addition they cause sodium to be excreted 
by inhibiting the action of aldosterone and also reduce the direct effect of angiotensin II on 
reabsorption of sodium and bicarbonate in the proximal convoluted tubules (Rang, Dale, 
Ritter, Flower, & Henderson, 2012). Their vasodilatation properties is further enhanced with 
the release of endogenous prostaglandins and nitric oxide from the vascular endothelium 
(Feldman, 2009). 
 
5.2 ARB 
These group of medication are often co-prescribed with ACEi in the management of HF and 
are particularly useful for patients who cannot tolerate ACEi. They act by blocking the 
angiotensin receptors thus improving exercise tolerance, reducing blood pressure and 
noradrenaline concentration in the blood (Feldman, 2009). 
 
5.3 Beta-blockers 
These drugs are very effective in reducing the level of circulating catecholamine, whose 
action on the myocardial cells can be deleterious. Beta blockers improve heart muscles 
contractility and also reduces much oxygen demand (Feldman, 2009). Clinicians have also 
been warned to start with a low dose and then progress gradually while assessing the heart 
rate and the blood pressure (NICE, 2010).   
 
5.4 Aldosterone receptor agonist 
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Aldosterone is increased in HF and often is associated with increased mortality. They act on 
the mineralocorticoids receptors thereby causing sodium and water retention, production of 
cytokines, vasoconstriction and myocardial cell as a result of increased production of 
inflammatory mediators. Aldosterone also causes fibroblast growth and platelet aggregation. 
This group of drugs act by preventing these events in HF (Feldman, 2009). 
 
5.5 Vasodilators 
This include the nitrates and hydralazine group of medications. Hydralazine reduces afterload 
by acting on the smooth muscles on the arterial wall while nitrates effect their vasodilation 
property on the veins thereby reducing pre-load on the heart. Thus decreasing venous return, 
cardiac output and pulmonary resistance (Oglive, 2007; Lejemtel, Sonnenblick & Frishman, 
2004). 
 
5.6 Diuretics 
These group of drugs are said to have the highest natriuretic efficiency of filtered sodium 
load and works by inhibiting the reabsorption of sodium ion and water from the thick 
ascending loop of the kidneys. This region of the nephron contains more sodium chloride 
channels which makes for intravascular volume and blood pressure reduction (Richardson, 
2007).  
 
 
6.0 EXERCISE INTERVENTION 
Data from cardiac rehabilitation programmes (CRP) has shown decrease in morbidity and 
mortality after MI, coronary artery bypass surgery, percutaneous coronary intervention, 
cardiac transplantation or valve repair in patients with heart failure. There is an 
overwhelming evidence that CR halves the cost of re-admission, improves quality of life, 
functional capacity and so remains one of the most clinically efficient and cost effective 
approach, in terms of managing cardiovascular diseases (British Association of  
Cardiovascular Prevention and Rehabilitation (BACPR), 2012). Those who participated in 
CRP have shown significant reduction in symptoms. Aerobic training is highly advocated, 
although other activities such as strength training, flexibility, stretching and balance exercises 
are also encouraged to help improve muscular health and strength. Nevertheless it has been 
shown, the mode of exercise notwithstanding, that interval training confers greater advantage 
compared to continuous type of exercises for HF patients. There is a growing evidence that 
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exercise intensity could be more vital than the duration of training and several methods have 
been proposed to calculate it. In general, depending on an individual’s aerobic capacity and 
other co-morbidity the duration can vary from the recommended 20 minutes 3 times per week 
for high intensity aerobic training to 30 - 40 minutes per day if moderate exercise is 
performed. Also 5 - 10 minutes period of warm-up and cool down must be included before 
and after each exercise (Perez-Terzic, 2012). Several factors should be considered prior to 
exercise and the training could be discontinued in the presence of any of these conditions:  
 
   
 
 
 
 
 
 
 
TABLE 2. CONTRAINDICATION TO EXERCISE TRAINING IN HF 
                                         (Asrar, Goy, Levinger, Wong & Hare, 2015). 
  
ABSOLUTE CONTRAINDICATION 
 
       RELATIVE  CONTRAINDICATION 
Progressive worsening of exercise tolerance or 
dyspnoea  at rest  
 
>2kg increase in body mass over previous 1-3 days 
exertion over previous 3-5 days  
Significant ischemia at low exercise intensities 
(< 2MET) 
 
Concurrent continuous or intermittent dobutamine 
therapy 
Uncontrolled diabetes  
 
Decrease in systolic blood pressure with exercise 
Acute systemic illness or fever 
 
New York heart Association Functional class IV 
Recent embolism 
 
Complex ventricular arrhythmia at rest or appearing 
with exertion  
Thrombophlebitis 
 
Supine resting heart rate > 100 beat per min 
Active pericarditis or myocarditis 
 
Pre-existing co-morbidities 
 Severe aortic stenosis 
 
Moderate aortic stenosis 
MET, metabolic equivalent 
 
The first scientific work concerning the benefits of work-associated exercise training (ET) 
was published by Morris and colleagues in 1953, who looked into the incidence of coronary 
artery disease (CAD) among London bus drivers. Their study showed that the incidence was 
higher among the sedentary bus drivers compared to the conductors. Subsequent studies have 
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continue to buttress the view that cardiovascular disease (CVD) is less likely among the 
physically active individuals. A recent meta-analysis showed that physical activity is 
associated with a marked reduction (35% reduction) in CVD risk and 33% risk reduction in 
all causes of mortality. In fact, exercise capacity is inversely proportional to risk of CVD and 
all causes of mortality, even after taking into consideration all cofounding variables. As a 
result of these outstanding evidence all the major CVD societies made exercise a basic 
component of health care management especially in the prevention of CVD, recommending 
at least 30 minutes of moderate intensity exercise 3 to 7 days a week (Adams & Niebauer, 
2015).  
There are varied opinion on the type of exercise programme and level of intensity considered 
appropriate for HF patients. On clinical basis, intensity of 70 – 80% of peak heart rate (HR) is 
usually preferred when using a symptom-limited exercise protocol (Asrar, Goy, Levinger, 
Wong & Hare, 2015). Nevertheless, the submaximal exercise intensities seem to offer better 
safety and the most recent Australian guidelines recommended the use of 40 to 70% VO2max    
with graded increment during the exercise starting from 10 to 15 minutes and increasing to 45 
to 60 minutes per session. Various studies have looked into the added benefits of higher 
intensities when compared to moderate or low intensities and outcome suggest that exercising 
at higher intensity has better effect on VO2max, left ventricular (LV) remodelling, endothelial 
function and mitochondrial function. Aerobic training has remained the preferred mode of 
exercise for HF patients; however, resistance training has also shown to have beneficial effect 
on muscle power, endurance and peripheral blood flow. A research which looked into 
resistance training versus usual physical activity in HF patients found a modest improvement 
in ejection fraction (EF) although there was no change in LV volume. In addition, a recent 
systematic review which examined the effect of resistance training alone or as an adjunct to 
aerobic training (AT) for improving cardiac function in HF patient also showed that 
resistance training improved six-minute walk distance compared to no training at all (Asrar 
Ul Haq, Goy, Levinger, Wong & Hare, 2015). 
 
Another study has examined the impact of combined aerobic and resistance training (ART) 
versus aerobic training alone in individuals with type 2 diabetes. During this research, a total 
of 47 participants were randomly assigned to aerobic (27) and ART (20) training group. After 
training result showed that both test improved body weight. However, the mean arterial blood 
pressure and endothelin-1 decreased after AT but increased after ART. It was also observed 
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that adiponectin levels rose by 54% after AT while it decreased by 13% after ART. Matrix 
metalloprotinease-2, tumour necrosis factor-alpha and monocytes chemo attractant protein-1 
levels significantly decreased after AT while it increased in ART. This study suggest that 
ART, as compared with AT, do enhance body weight reduction, however, it has less effect on 
insulin sensitivity and endothelial factors, adipokines and proinflammmatory makers released 
(Lucotti et al. 2011). Further studies have compared the impact of moderate continuous 
training (MCT) at 70% of peak HR and aerobic interval training (AIT) at 90% of peak HR in 
27 elderly (>70years) patients who were randomly assigned to three groups after a stable 
post-myocardial HF.  The training was 3 times per week for 12 weeks and the findings of this 
study showed that AIT was superior to MCT with regards to reversing LV remodelling, 
aerobic capacity, endothelial function and quality. It showed that high intensity training when 
compared to an individual’s maximum oxygen capacity is more profitable even in the older 
subjects (Wisloff et al. 2007).  
 
7.0 CONCLUSION   
In summary, there is no exact direction on the preferred mode of exercise for HF patients, 
however combined resistance and cardiovascular exercises may likely offer beneficial effect 
as they would both act centrally and peripherally.  
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9.0 ABSTRACT 
 
9.1 BACKGROUND   
Flow mediated dilatation (FMD) is attenuated in Heart failure (HF) and this leads to 
worsening of symptoms. In Europe, the number of HF patients is estimated to be 
approximately 15 million and that number is set to rise due to ageing of the population. A 
research conducted between 1999 and 2000, showed that mortality rate was 50% in males 
and 46% in female within 5 years after the diagnosis of HF. It is estimated that 50% die 
within four years whereas the other 50% do not survive beyond the first year after diagnosis. 
Endothelial dysfunction has been implicated in disease progression, however, it is known that 
increase in physical activity improves and corrects endothelial dysfunction.   
 
9.2 OBJECTIVES 
The aim of this systematic review is to examine (i) the effect of exercise modalities (aerobic, 
strength or combined) on FMD in HF and (ii) to determine which modality confers the 
greatest benefit and to what extent.  
 
9.3 METHOD 
The following databases (MEDLINE, Cochrane library, PubMed, science direct,) were 
searched for sources that met the inclusion criteria such as (i) randomized controlled trials of 
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exercise with non-exercise, routine care or sedentary lifestyle. (ii) Duration of the exercise 
should be at least 2 weeks (iii) age of participant should not be below 18 years. (iv) 
Endothelial function as measured by FMD before and after the intervention. 
 
9.4 RESULTS  
14 studies were included in this review with a total of 583 participants predominantly with 
reduced ejection fraction (<40%) and New York Heart Association II and III. Compared with 
control, there were significant improvement (p< 0.005) in endothelial function as measured 
by FMD in the exercise group across all the studies involving HF with reduced ejection 
fraction (HFREF). Aerobic exercise at a moderate intensity resulted in significant increase in 
FMD in 12 studies but higher outcome were noted when it was performed in combination 
with resistance training at a higher intensity. Conversely, one study done among HF with 
preserved ejection fraction (HFPEF) did not show any significant improvement.                    
 
9.5 CONCLUSION 
Exercise training is effective in correcting the prevailing endothelial dysfunction common 
with HF. Combination of aerobic and resistance training as against only aerobic at moderate 
to high intensity offers the greatest benefit.   
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10.0 INTRODUCTION  
 
The term endothelial dysfunction often refers to a variety of pathologies including altered 
anti-inflammatory and anti-coagulant properties of the endothelium, impaired regulation of 
vascular growth, and abnormality in vascular remodelling. However, in this review it has 
been majorly used to describe dysregulation in endothelium-dependent vasodilatation 
commonly associated with the absence of nitric oxide (NO) ubiquity on the vascular wall 
(Cai & Harrison, 2000). Endothelial dysfunction, typically characteristic of atherosclerotic 
vessels, has shown to impact negatively on HF patients (Lima de Melo Ghisi, Durieux, Pinho 
& Benetti, 2000). There is a large body of evidence suggesting the attenuation of NO in heart 
failure and this has been implicated in disease progression (Katz et al. 2004).NO is needed 
for vascular endothelial growth factor (VEGF) –induced angiogenesis and its absence may be 
the reason for the reduced capillary density of cardiac muscles, a condition which have been 
shown to result to cardiomyopathy (Giordano et al. 2001). In addition to its anti-thrombotic 
property, NO is thought to maintain the peripheral vessels in a patent state, thereby reducing 
afterload on the heart, especially in conditions such as CHF. Accumulating evidence suggest 
that the absence of endothelium derived NO contributes to the abnormal vasoreactivity 
response commonly reported in CHF both in the coronary and peripheral vasculature. As a 
result, chances are that the progression and increased mortality outcome from CHF may be 
closely connected to the state of the vascular endothelium (Fischer et al. 2004).   
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Flow-mediated dilation (FMD), a term which describes the vasodilatation induced by speed 
of blood flow, strongly correlates with invasive testing of coronary endothelial function 
(Dean, Libonati, Madonna, Ratcliffe, & Margulies, 2011; Raitakari & Celermajer, 2000). 
Endothelial function as evaluated by FMD is a reliable and commonly applied method of 
evaluating the endothelial integrity. FMD is considered as the vasodilatation induced in 
response to a sudden increase in shear stress; as a result, is an effective direct marker of 
vasoreactivity (Gori et al. 2011). It is associated with regulation of arterial diameter with 
increase in blood flow physiologically triggering the release of NO. However, impairment of 
this function is very common in certain pathological states and peripheral vascular 
endothelial dysfunction has been frequently reported in HF and is an important indication for 
prognosis (Dean, Libonati, Madonna, Ratcliffe, & Margulies, 2011). 
 The beneficial effect of exercise training on endothelial function has been documented. 
Recent studies have demonstrated that exercise leads to a significant rise in endothelial NOS, 
which is a precursor to NO. Furthermore, physical activity is known to activate the release of 
extracellular superoxide dismutase which also contributes to increase level of NO. In 
addition, NO is also known to attenuate the effect of platelet aggregation and possesses anti-
oxidant, anti-proliferative and anti-apoptotic properties (Lima de Melo Ghisi, Durieux, Pinho 
& Benetti, 2000). Although several pharmacologic therapy has shown to improve endothelial 
dysfunction, various studies have supported the effective role of exercise in this respect. 
Therefore, the aim of this section is to investigate: 
1. How the different exercise modalities may affect the endothelium in HF patients?  
2. To identify which modality confers the greatest benefit and whether these effect is similar 
for both preserved ejection fraction and reduced ejection fraction? 
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 11.0 METHODOLOGY 
 
 11.1 Search strategy 
 
The Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) 
statement was the pattern of choice upon which this systematic review was developed and 
structured (Moher, Liberati, Tetzlaff, Altman, & Prisma Group, 2009). 
   
 
 
11.2 Data sources and search  
 
A wide range of databases were searched, as these databases were easily accessible either 
through the University of Chester portal or via online. Initial search showed that the earliest 
study on the impact of exercise on vascular function may have been conducted as far back as 
1986 (Lejemtel, Maskin, Lucido, & Chadwick, 1986). Therefore, bibliographical databases 
were searched for relevant studies from 1986 up to mid-August 2015. In order to avoid 
irrelevant outcomes, searches were restricted to only human studies, young adults were 
excluded (below 40 years) and participant must have been diagnosed to have heart failure 
(NYHA I-IV) prior to the intervention.   
Studies included were obtained by two main route. First, a detailed search for randomised 
control studies/trials in some relevant databases to clinical exercise such as: science direct, 
Entrez PubMed, Scopus, Medline, the Cochrane database of Systematic Review, the 
Cochrane Central Register of Controlled Trial (CENTRAL) and the University library search 
website was undertaken. The Cochrane library, ProQuest, Sport discus and (Cumulative 
index to nursing and allied health literature) CINAHL were also searched to identify all 
possible related studies.  
The titles of the research papers were used initially in finding relevant articles and the 
Medical Subject headings (MeSH) “exercise training” and “heart failure” were keywords  
used alone and in combination with other words like  “aerobic exercise”, “resistance 
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exercise”,  “physical activity”, “physical training”, “strength training”, “exercise training”, 
“exercise”,  “endothelial function”, “endothelial dysfunction”, “flow-mediated dilatation”, 
“vascular reactivity”, “chronic heart failure”, “congestive heart failure”. 
Searches were made with high sensitivity although there is the likelihood of this reducing 
precision. Numerous and unnecessary combinations of ideas were avoided while the use of a 
wide range of search terms were frequently applied with the aid of the Boolean operators 
such as “AND”, “OR”, “NOT” or “AND NOT” to enable a more thorough search outcome. 
Since it is imperative that systematic reviews take a pattern for its search strategy which 
should reflect consistency and coherency throughout the research; a relevant search strategy 
was subsequently designed to be able to identify all related studies within the inclusion 
criteria and as such reduce bias towards studies which may show significant outcome; thus 
avoid the risk of overestimation of the intervention effect (Centre for reviews and 
dissemination, 2009; Ryan, Hill, Prictor, & McKenzie, 2013). 
This systematic review has been conducted as part of MSc dissertation and so a single 
reviewer has seen through the whole process.  
 
 
 
11.2.1 Minimising the risk of bias  
 
The Cochrane collaboration tool for assessing risk of bias was used to evaluate the studies 
included in this review (Ryan, Hill, Prictor, & McKenzie, 2013). 
 
11.2.2   Grey literature searches  
 
Grey literature are often referred to as those studies that are not formally published in 
journals or books.   
        
11.2.3 Hand searched articles   
 
Studies were also hand searched in addition to accessing the above mentioned database in 
order to maximise the number of studies retrieved and used in this systematic review. 
Journals were individually searched for articles that assessed the impact of exercise on the 
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endothelial function in heart failure patients in a randomized controlled trial setting. The 
online version of these journals that were looked into:  
       
       British Heart journal 
       The journal of the American Medical Association (JAMA) 
       American Heart Journal 
       Circulation 
       European heart journal 
       Heart 
       The American journal of cardiology 
       Cardiovascular prevention rehabilitation 
       Archives of internal Medicine 
       The lancet 
       The New England journal of medicine 
       Archives of physical medicine and rehabilitation 
        
During the second phase, the reference list on the individual studies were used to conduct a 
more detailed search. Randomized controlled trials were identified and studies that grouped 
participant into “exercise only” or used additional intervention to access the endothelial 
reactivity was eligible to be included in this review. All studies were accessed free online 
through University of Chester online IBIS learning resource facility.  
 
 
 
  11.3 SELECTION CRITERIA 
 
In order to improve the quality of studies included, certain eligibility criteria (table 3) were 
considered a pre-requisite. An initial eligibility criteria was cautiously applied which included 
more studies so as to avoid leaving out any relevant study. 
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Table 3.                         Initial eligibility screening criteria 
 
PICOS CONCEPT                                                       Inclusion / Exclusion 
Study design                                                         Was the study RCT? 
                                                                              Was it a primary research? 
 
Population                                                             Were human subject included? 
                                                                              Were the subject over 18 years? 
                                                                              Were the subjects diagnosed of HF? 
                                                                                                   
Intervention                                                           Did the study use aerobic or resistance 
training or both.    
                                                                              Was the intervention after the diagnosis?               
 
After the initial eligibility screening, the full text of the studies were gotten from; freely 
available sources, subscription held by the University of Chester library, and when not 
available from the above sources then application was made through the University of 
Chester Library for an inter-library loan. 
 
All the full text studies were examined with the full eligibility criteria (table 4).  
 
 
Table 4.                                   Full eligibility screening criteria 
PICOS                                           Inclusion   criteria                                                      Exclusion criteria 
Study Design          Was the study fully published?                   Studies in Non-English language  
                                      Was the study published in English     Studies that published abstract  
  Language?           only. 
 
                                       Was the study a primary research?                Review articles, news items,  
                                       Was the study a RCT?                                           proposed studies, other study  
                                       Did the study last up to two weeks?                  design apart from RCT, 
                                                                                                                            editorials and letters.  
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Outcome:                      Did the study include EF?                                    EF not specified 
                                      Did the study include EF data                               EF pre and post exercise 
                                      pre and post exercise?                                        not mentioned? 
 
Population:                   Did the study include only human                         Non HF patients 
                                           subject?                                                               If the stage of HF was not  
                                       Did the study include adults (>18 years)                    reported. 
                                       Did the study include heart failure patients? 
                                       Did the study specify the stage of HF?  
 
Comparators:            Were the controls HF patients? AND                  Non HF patients controls 
                                    Were the controls assigned to the                        HF control who were    
                                      Usual care? OR Required to maintain                    assigned to placebo exercise  
                                      a usual level of exercise? OR asked not                  with > moderate effect on  
                                      to exercise at all?  Were control assigned                  EF.  
                                      to placebo exercise with mild effect on EF.  
 
Intervention:                                            
                                   Was the intervention aerobic or resistance              Exercise intervention with 
                                       exercise or a combination of both?                             minimal effect on energy 
                                     Did the exercise take place after the                            expenditure (e.g. yoga, 
                                      the diagnosis of HF?                                                    mild stretching etc.) 
                                     Were the details of the exercise, in terms of            Exercise interventions 
                                      Frequency, time, intensity, and mode reported?           which were part of other 
                                     Did the exercise meet the criteria for high quality     component (E.g. exercise 
                                     training study?                                                               -diet; exercise-CBT  
                                                                                                                             except data for exercise  
                                                                                                                             only group is available). 
      EF = Ejection fraction; HF= Heart failure; CBT = Cognitive behaviour therapy 
 
 
 
After the initial screening, it was apparent that abstract only publication would be excluded 
from the review since they do not provide the level of details required for the study.  
      
11.4 HANDLING DUPLICATION   
 
In order to avoid including studies twice, the specific details of all the studies that met the 
inclusion criteria were compared one against the other and any duplicate that were identified 
was treated as a single research but references were made to all the publication in the final 
review (Centre for Reviews and Dissemination, 2009, p.25; Higgins & Deeks, 2011). 
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11.5 QUALITY ASSESSEMENT 
 
The importance of assessment of the quality of controlled trials cannot be overemphasized as 
differences in the quality of the studies may affect the conclusions reached (Armijio Olivo et 
al, 2008). There are mainly three methods which have proven effective in accessing the 
quality of studies. They include: individual markers, scales and checklist (Jadad et al. 1996) 
(table 3). Scales and Checklist are examples of instrument which can be used to assess the 
methodological quality of clinical trials. Although both types have been used 
interchangeably, they are not exactly the same. Both scales and checklist include items which 
measures quality but the individual responses to scale measurements can be summed up 
giving an overall overview of the trial quality (Armijio Olivo et al, 2008). A number of scales 
and checklist have been used to asses RCT, however a 5-item scale developed by Jadad and 
his colleagues is the only known scale develop with a standard scale development technique. 
Jadad reported that the scores were lower and more consistent if the quality assessment was 
blinded. However, a study has shown that blinding had no significant effect on Jadad score 
(Clark et al. 1999).   Although this scale is a pain-validated tool, which was not designed to 
check specific details on physical therapy, it is widely used in physical therapy and other 
related areas (Armijio Olivo et al, 2008).   
 
This instrument can be used to measure the likelihood of bias in a research and should not 
take more than 10 minutes to analysis each study and there is no right or wrong answers 
(Jadad et al, 1999). It could be used by researchers to assess study protocols; by readers and 
editors of journals to find out research papers that are scientifically authentic. Individuals 
involved in systematic review or meta-analysis may find it resourceful in performing 
differential analysis based on the quality of each study included in their review. Patients 
might find it helpful in evaluating the validity of any evidence presented to them by health 
professionals (Jadad et al. 1999). 
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Table 5.             Jadad scale for reporting randomized control trials 
 
ITEMS MAXIMUM 
POINTS 
DESCRIPTION  EXAMPLES 
Randomization      2 1 point if randomization is mentioned  
  
 
1 additional point if method of 
randomization is          appropriate 
 
 
 
Deduct 1 point if method of 
randomization is inappropriate (minimum 
= 0). 
The patients were 
randomly assigned into 
two groups. 
 
The randomization was 
accomplished using 
computer-generated 
random number list, 
coin toss etc. 
 
The group assignment 
was accomplished by 
alternate assignment, by 
birthday or hospital 
number etc.  
Blinding        2 1 point if blinding is mentioned  
 
 
1 additional point if method of blinding is 
appropriate 
 
 
 
Deduct one point if the method blinding is 
inappropriate (minimum = 0) 
The trial was conducted 
in a double blinded 
manner 
 
Use of identical tablets 
or injectable, or tablets 
with similar appearance 
but tastes differently  
 
Masking was incomplete 
An account of 
all patients 
       1 The fate of all patients in the trial is 
known and where there is no data 
explanations are given. 
40 patient were enrolled 
in the trial, however 2 in 
the experimental group 
and 3 in the control 
group were 
discontinued due to 
break in the protocol 
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11.6 GUIDELINES FOR ASSESSMENT  
 
11.6.1 Randomization 
 
The method generating the sequence of randomization will be considered appropriate if 
allows each participant of the study to have equal chance of receiving the same intervention 
and the investigators could not predict which treatment is next. Methods using date of birth, 
hospital numbers or alternation to allocate participant should not be considered. 
 
11.6.2 Double blinding 
 
Only on the note that the word “double blind” was used in the study can a study be regarded 
as double blind. The method will be regarded as appropriate if and only if, it is stated that 
neither the person doing the assessment and the study participant could identify the 
intervention being carried out or if in the absence of such statement the use of active 
placebos, identical placebo or dummies is mentioned. 
 
11.6.3 Withdrawals or dropped out 
 
Participants who were included in the study but who did not complete the observation period 
or who were not included in the analysis must be described. The number and the reason for 
the withdrawal in each group must be stated. If there were no withdrawals it should also be 
stated in the article. If there no statement on withdrawal, this item must be given no points 
(Jadad et al. 1996). 
 
Therefore the Jadad scale may be very useful, quick and easy- to-use tool in the assessment 
of trials included in the study. For example: 
 
Table 6.   
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STUDY 
 
Kobayashi et al. 2003 
1 Was the study described as randomized? 
 
 1 
2 Was the study described as double blind?   
 
0 
3 Was there a description of withdrawals or dropped out? 
 
1 
4 Was the randomization described as appropriate? 
 
1 
5 Was the blinding described as appropriate? 
 
0 
             Total Jadad score 3/5 
  
 
 The Jadad 5- point’s scale was used to evaluate included studies and articles that achieved 3 
and above were included in this review so as to reduction the risk of publication selection 
bias (Jadad et al. 1999). 
 One of the limitations to this scale is its appealing simplicity which may lack empirical 
evidence (Emerson, 1990; Schulz, 1995b). Since this involves assigning different values to 
items in the scale, its validity may be difficult to assess. Moreover, it places more emphasis 
on reporting than the actual process of the trial conduct and as such does not take into 
consideration one of the most potential bias namely allocation concealment(Juni, 1999). 
Therefore such scales that measure more of reporting quality like the Jadad scale should not 
be used to measure methodological quality. Rather the important methodologic components 
such as concealment of treatment allocation, handling of attrition bias and blinding of the 
outcome assessment could be identified and assessed individually (Huwiler-Muntener, Juni, 
Junker & Egger, 2002).                                      
 
 
 11.7 DATA COLLECTION 
 
The included studies in this review came from a variety of sources. Most of the searches were 
done in the relevant data bases to extract all possible published or unpublished studies.  The 
search yielded some studies which were compared against the inclusion or exclusion criteria; 
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moreover the references provided by the search were used to retrieve electronic articles from 
the University of Chester Library or inter-library loan were necessary. 
In addition, a manual search was also conducted while looking through the references of the 
online results. 
 
                                          
 
 11.8 STATISTICAL ANALYSIS 
There was no statistical data that was analysed during this study; however, when data were 
arraigned in a table format to show any change from the baseline information and was 
depicted with mean ± standard deviation (SD) which is statistically significant (p <0.05). 
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12.0 RESULTS 
12.1 STUDY SELECTION 
 
Studies were included or excluded after comparing them with the PICOS criteria and after 
full text review, only 14 studies met the inclusion criteria (figure 1).   
 
   •7083 records were identified from the data bases                          • 217 records identified from other sources 
    Medline = 68                  ProQuest = 1964                                                     Books hand searched = 58 
    Cinahl =12                       Cochrane lib. = 22                                                  Journals hand searched = 159 
    Sport discus= 17             Science direct = 4560   
   Pub med. =440   
 
 
 
                                                          
                          • 7300 records identified                                                    •2649 duplicate 
                                                                                                                    Were removed 
  
 
 
              •4651 records screened: title, abstract against                                                      •4050 excluded did not meet                                                             
                   the inclusion/exclusion criteria                                                                                   inclusion criteria 
 
                                                                                                                                               
                                                           
                                                                                                                                                                             587 studies were excluded 
             • 601 full text articles accessed for eligibility against the                                                           •Reviews only=87 
                                Full eligibility criteria                                                                                                      •No exercise= 56 
                                                                                                                                                                            •Abstract only =38 
                                                                                                                                                                  •Non-English =126 
                                                                                                                                             •Non-RCT =59 
                                         •14 studies                                                                                                      • Non-HF =221 
                               were included in the final review                                                                                                                      
                                                                                                                                               
                        Figure 1. Flow diagram of sequence of data management throughout the review                       
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12.2 GENERAL CHARACTERISTICS 
 
The publication year of the papers included in this review ranges from 1998 to 2015 with 
most published between 2000 and 2015. They were all written in English language. The 
studies between 1986 and 1998 did not meet the inclusion criteria. The aim of the studies 
were to examine the effect of exercise training on the endothelial function in HF patients. 
Nine out of the 14 studies measured additional variables during their research. One of the 
studies (Belardinelli et al. 2005) determined the impact of exercise on the endothelium of 
CHF patients with implantable cardioverter defibrillators and cardiac resynchronization 
therapy whereas another trial (Hambrecht et al. 2000)    looked at the additive effect of L-arg. 
to physical activity in correcting endothelial dysfunction in CHF. 
 
12.3 POPULATION CHARACTERISTICS 
 
Eight of the studies were done in European countries like Germany (5 studies), Italy, Greece 
and Norway (1 study each), USA (2 studies), Australia (2 studies), and two from Japan. The 
number of participant varied between 20 to 120 individuals with most studies predominantly 
male subjects. Six out of 14 studies included only male participants in their exercise training 
and in one study the sex of the subjects were not clearly indicated. All the studies examined 
elderly (adults) age group and majority of their age were between 41 and 75 years. One study 
had participants who were above 80 years. Eight studies included female and male in their 
research others did not. 
Most of the participants in the study were in NYHA II or III; and majority of them were 
expected to be clinically stable prior to exercise the enrolment (table 7). 
The total number of participants included in these studies were 583. Of these, 314 were 
randomised to an exercise programme whereas 269 were in control/comparison group. Only 
35 female partook in these studies compared to 426 male subject. The gender for the 
remaining 120 participants were not indicated (table 7).  
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12.4 FMD MEASUREMENT 
 
The various studies evaluated FMD mainly by two methods (table 8). 12 studies made use of 
Ultrasound technique following reactive hyperaemia and 10 out of these underwent 
supervised cycle ergometry exercise while the other two performed supervised walking on 
the treadmill. The remaining 2 studies measured FMD using plethysmograph technique and 
while one of them performed resistance training the other did aerobic exercise.  
  
12.5 STUDY DESIGN 
 
All the 14 studies included in this review where only RCT which had achieved at least 3 
score on Jadad scale. In addition, to FMD most of the studies also reported other variables 
such as (quality of life, peak oxygen consumption, exercise capacity etc.) but only data on 
endothelial-dependent vasodilatation is reported in this review.  
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Table 7. Characteristics of included studies 
 
Authors 
(date) 
Participants 
(Age, Sex, group) 
Intervention 
studied 
Type of 
exercise 
Time, 
Frequency 
& Duration 
of each 
session 
Intensity Outcome(s) 
Kobayashi et 
al. 2003 
 28 CHF ( M=20,F=8) 
Exercise group(55±2)yr. 
14(M=12,F=2) Control 
group (62±2)yr. = 
14(M=8, F=6)  
 
Exercise group: 
LVEF : (29±2)% ; 
Control group: 
LVEF: (33±2)% 
NYHA (II – III)  
Aerobic 
Exercise only 
Supervised 
cycle 
ergometer 
training 
 
2-3days/wk 
in two 15  
minutes 
session for 3 
months 
 
 
Used HR at a 
ventilatory 
threshold for 15 
minutes each 
session; but if 
irregular then  
RPE= 13 
(Borg’s scale) was 
used 
 There was no significant change from 
baseline values of brachial artery FMD in the  
HF exercise group (4.34±0.45 vs 4.56 ± 0.43) 
However, there was a significant increase 
in FMD in the tibial artery of HF exercise 
group from their baseline values(3.64± 
0.26 vs 6.44 ± 0.56) p<0.01 
Parnell et al. 
(2002) 
21 CHF (M=19, F=2)  
Exercise group: 
11(M=10, F=1) 
Control group: 10(M=9,     
F=1) 
 
Exercise group: 
LVEF: (25± 2)%; 
Control group: 
LVEF: (24± 3)% 
NYHA(II – III) 
Aerobic 
Exercise only 
Walking, 
light hand 
weights 
and 
stationary 
cycling 
 
Progressed 
from 30 
minutes 
3times/wk. 
to 60 
minutes/day 
for 5-7 days 
per week for 
8 weeks. 
50 – 60% 
maximum heart 
rate 
Significant increase in 6MW test from baseline 
value (474± 27m to 547±34 m). p=0.008 
Decrease in HR was recorded in the 
exercising group from baseline values 
(66±3 to 62± 2 beat/min; p= 0.037 but no 
significant change occurred in the control 
group. 
Systemic arterial compliance significantly 
increased only in the trained group from 
(0.57± 0.11a.c.u to 0.77± 0.14 a.c.u) 
Belardinelli 
et al. 2005 
  52 CHF (all male) 
Exercise group: ICD 
(n=15), ICD +CRT (n=15); 
Control group: ICD 
(n=12), ICD +CRT (n=10) 
Aerobic 
Exercise only 
Stretching, 
Supervised 
electronica
lly braked 
cycle 
Warm up 
(15min) , 
braked cycle 
(40mins), 
5mins 
60% VO2max  The exercise group had significant increase in 
their endothelium-dependent vasomotor 
dilatation irrespective of the type of device 
they received (p< 0.001). Improved QoL, 
Reduction in LV end-systolic volume index, 
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NHYA II (n=29); III(n=23) 
 
loadless 
recovery for 
8 weeks 
increase in LV ejection fraction, and decrease 
in peak early filling velocity were all significant 
in the trained subjects with CRT. 
 
Bellardinelli 
et al. 2004 
59 CHF (all male) 
Exercise group:(n=30) 
Control group: (n=29) 
NYHA II (n=33); (n=26) 
 
Aerobic 
Exercise only 
Supervised 
cycle 
ergometry 
Warm up (15 
min), braked 
cycle 
(40min) and 
5 min 
loadless 
recovery 
3times/week 
for 8 weeks 
60%  VO2max At 8 weeks the FMD had significantly 
improved only in the trained subject s from 
baseline values (2.29±1.13% to 5.04±1.7%). 
       
Linke et al. 
2001 
22 CHF (all male) 
Exercise group: (n= 11); 
LVEF:(26±3)% 
Control group: (n=11) 
LVEF: (24± 2)%  
 NHYA II (n=16); III (n=6) 
Aerobic 
Exercise only 
Supervised 
electronica
lly braked 
cycle 
ergometry 
6 times/day 
for 10 min 
each over 4 
weeks 
70% VO2max  After 4-weeks of training Ach-mediated, 
endothelium –dependent vasodilatation 
significantly increased only in the exercised 
group (p<0.001). 
FMD significantly increased from the baseline 
value (374±57 to 570±76 µm (p<0.01) vs 
control group at 4 week).   
Hambrecht 
et al. 2000 
40 CHF (all male) 
Control group: (n=10) 
LVEF: (19±3)% ; 
Exercise 
group:(n=10)LVEF: 
(18±3)%; 
Exercise + L-arg:(n=10) 
LVEF: (19±3)%;  
L-arg group:(n=10) 
LVEF: (18±3 )%  
 
NHYA II (6); III(34) 
Aerobic 
Exercise and 
L-arg 
Hand grip 
ergometer 
training 
6 times/day 
for 
unspecified 
period over 
4 weeks 
70% VO2max  After 4- weeks of exercise training, Ach-
induced vasodilatation increased four times in 
exercise group from (2.1±0.1% to 8.6± 0.9%) 
(p< 0.001) 
Selig et al. 
2004 
39 CHF(M=33;  F=6) 
Exercise group:(n=19) 
Resistance 
Exercise only 
Hydraulic 
resistance 
5-min warm-
up  
Moderate  
intensity 
After 3 months of training the FBF significantly 
improved in response to all 3 levels of 
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LVEF: (28 ±7)%  
Control group: (n=20) 
NHYA II & III 
training: 
arm &leg 
cycling 
ergometer
s, set of 5-
stairs, 
shoulder 
press/pull, 
elbow 
extension/f
lexion, 
knee 
extension/f
lexion 
& cool 
down;  
Upper body 
15%,30% & 
45% 1RM 
sessions per 
week for 3 
months 
intensities. Control group did not record any 
significant change 
Anagnostako
u et al. 2011 
28 CHF (M=23; F=5) 
Exercise group 
1(interval training): 
(n=14) 
LVEF: (36±13)% 
Exercise group 
2(combined): (n=14) 
LVEF:(39±11)%  
NYHA I (n=8); II 
(n=17); III (n=3) 
Aerobic OR 
Combined 
(Aerobic & 
Resistance) 
exercise  
Electromag
netically 
braked 
cycle 
ergometer 
40 minutes 
cycle(aerobic
) OR  
3 Sets of 10-
12 Rep with 
10 sec. rest 
in-between 
for 20 
minutes + 20 
mins Cycle 
(combined)  
Three times 
a week for 
36 sessions 
50% of SRT 
 
And  
55% to 65% of 
the 2-RM for 
lower limb and 
10-RM for upper 
limb 
After 3 months of rehabilitation, the 
combined group showed significant 
improvement in FMD from baseline absolute 
values of (0.44± 0.24) mm to (0.72± 0.2) 
mm; whereas interval training group 
result were not significant. 
Erbs et al. 
2010 
37 CHF (all males) 
NYHA IIIb 
Exercise group: (n= 18) 
Control group: (n=19) 
LVEF: (24±2)% 
Aerobic 
exercise only 
Bicycled 
ergometer 
and 
supervised 
group 
training 
(walking, 
3 to 6 times 
per day for 3 
weeks 
followed by 
home-based 
20 to 30 
mins 
50% VO2max  Exercise training for a period of 12 weeks 
resulted in significant improvement in FMD 
from (6.1±2.5 to 13.6 ± 2.2) % which 
correspond to absolute increase in 
internal diameter of 415± 86µm; In 
contrast, the control group did not show 
50 
 
calisthenics 
and non-
competitiv
e ball 
game) 
unsupervise
d cycle 
training for 
12 weeks; 
with one 
supervised 
group 
training 
any change in FMD. 
Hambrecht 
et al. 1998 
20 CHF (all males) 
Exercise group: (n=10) 
LVEF: (24± 4)% 
Control group: (n=10) 
LVEF: (23±3)% 
NHYA: I &III  
 
Aerobic 
exercise only 
Supervised 
electronica
lly braked 
bicycle;  
Home-
based 
bicycle 
ergometer 
and one 
group 
training 
session per 
week 
6 times/day 
for 10 mins 
for 3 weeks 
followed by 
2 times/day 
for 40 mins, 
5 days/week 
for 6 months 
70% VO2max  After 6 months of aerobic exercise, there was 
significant improvement in peripheral blood 
flow from baseline values (1.6± 2.4 to 7.6± 
3.4) cm/s (p< 0.05 versus control group) at 
60µg/min acetylcholine, and from (2.0± 
2.0 to 10.9± 3.4) cm/s (p< 0.05 versus 
control group) at 90µg/min acetylcholine. 
Wisloff et al. 
2007 
27 (CHF) (M=20; F=7) 
Exercise group: 
MCT(n= 9) 
AIT (n=9) 
Control group: (n=9) 
LVEF: <40% 
NHYA (2.5±0.5)  
Aerobic 
exercise only 
“Uphill” 
treadmill 
walking 
Supervised 
training 2 
times per 
week: 
10mins 
warm-up; 47 
mins training 
and 3mins 
cool down  
and home-
based 
training once 
every 3 
weeks 
MCT (70 to 75)% 
of HR max 
 
AIT( 90 to 95)% of 
HRmax 
 
Control: 70% of 
HRmax 
At the end of 12 weeks, FMD had significantly 
increased in AIT group compared to MCT 
group. Control group did not show any 
significant change 
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Control 
group: were 
to follow 
advice from 
their doctor; 
in addition 
perform 47 
mins 
continuous 
treadmill 
walking at 
70% of peak 
HR every 3 
weeks  
Sandri et al. 
2015  
60 (CHF) and 60 (RC) 
Sex =not recorded 
RC ≤55yrs (n=30) 
RC ≥65yrs (n=30) 
CHF≤55yrs(n=30) 
CHF≥65yrs(n=30) 
LVEF: <40% 
Aerobic 
exercise only 
Supervised 
bicycle 
ergometer  
and one 
group 
training 
session 
(walking, 
calisthenics 
and ball 
games) 
 
Control: 
usual care 
 4 times/day 
15 to 20 
mins for 4 
weeks with 5 
mins warm-
up and cool 
down for 4 
weeks 
60 to 70 %           
VO2max  
Exercise training resulted in significant 
increase in FMD among the younger (11.3 ± 
2.5% to 15.7± 1.9%) and older CHF patients 
(10.5± 1.5% to 14.9± 2.2% p<0.05) versus 
control group. 
Kitzman et 
al. 2013 
63 (HFPEF) 
Exercise group: (n= 32) 
Control group: (n= 31) 
NHYA II & III 
LVEF: >50% 
Aerobic 
exercise only 
Walking on 
track and 
cycle and 
arm 
ergometer 
10 min 
(warm-up) 
Trained from 
20 mins to 
40 mins 
10 min 
40 -50% to 70% 
HRR 
After 16 weeks of training, there was no 
significant change in the FMD in the training 
group. 
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(recovery) 
 
Ozasa et al. 
2012 
27 (CHF) (M=12), ( F=15) 
Exercise group: 
MACG: (n=13) 
C-ET: (n= 14) 
 
NYHA II (n=3); III (n= 24) 
LVEF: 46.0±14.4 % 
 
Aerobic 
exercise only 
Machine-
assisted 
cycling and   
C -ET 
MACG: 20 
mins (warm-
up) 
stretching; 
15 mins 
cycling  
C-ET: 15 
mins gait 
training and 
5 mins (cool 
down) 
stretching  
< 30% HRR After 2 weeks of training a significant increase 
in RH-PAT index in MACG was observed from 
(1.59±0.52 to 1.93± 0.63). No change was 
seen in C-ET group.   
 
NYHA= New York Heart Association; MACG= Machine-assisted cycling group; C-ET = Conventional training; HRR= Heart rate reserve; RH-PAT 
= reactive hyperaemia peripheral arterial tonometry; LVEF = Left ventricular ejection fraction; CHF = Chronic heart failure; HFPEF = Heart failure 
with preserved ejection fraction; FMD = flow-mediated dilatation; RC = Healthy subjects; MCT = Moderate continuous training; AIT= Aerobic 
interval training; FBF= Forearm blood flow; L-arg. = L-arginine; CRT = Cardiac resynchronization therapy; ICD = implantable cardioverter 
defibrillator;   VO2max = Maximum oxygen capacity; HRmax = maximum heart rate; MW = meter walk; RPE = Rate of perceived exertion.. 
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Table 8.  Characteristics of studies included (FMD measurement)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                          STUDY 
 
 
             How FMD was measured. 
Kobayashi et al. 2003 Two-dimensional ultrasound  
 
Parnell et al. 2002 Non-invasive applanation tonometry and 
Doppler aortic velocimetry  
Belardinelli et al. 2005  Ultrasound probe 
  
Bellardinelli et al. 2004 
 
Ultrasound probe 
 Linke et al. 2001  
 
High precision ultrasound 
 Hambrecht et al. 2000  
 
Ultrasound and Doppler transducer 
 Selig et al. 2004  
 
Venous occlusion plethysmography 
 Anagnostakou et al. 2011  
 
Doppler ultrasound  
Erbs et al. 2010  
 
High resolution ultrasound 
 Hambrecht et al. 1998  
 
Doppler guide wire with Doppler ultrasound  
Wisloff et al. 2007  
 
Ultrasound 
Sandri et al. 2015  High resolution ultrasound scanning echo-
tracking angiometer 
 Kitzman et al. 2013 
 
Bisound phase II ultrasound system  
Ozasa et al. 2012 
 
Plethysmographic technique  
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13.0 DISSCUSSION 
 
 
13.1 VASCULAR EFFECT OF EXERCISE TRAINING 
 
CHF is a complex syndrome which may be characterised by increased vascular resistance due to 
autonomic and hormonal irregularities. The resulting vicious cycle continues to deteriorate the 
endothelial vascular integrity and further worsening outcomes (Belardinelli, Lacalaprice, Faccenda, 
Purcaro & Perna, 2005). This present review however attempts to validate the theory that exercise 
training improves endothelial-dependent vasodilatation and has been considered as the single most 
important indicator of endothelial function. Endothelial dysfunction has been proposed to reduce the 
distensibility of conduit vessels. In CHF patients, endothelium-derived relaxing factor-mediated 
increase in distensibility are impaired leading to a worse condition for the heart (Ramsey et al. 1995). 
It has been put forward that these peripheral vascular abnormalities could be attenuated in CHF 
following exercise training. However, the exact mechanism by which this is achieved is not 
completely understood. Previous studies have shown that systemic arterial compliance improves with 
regular training, this improvement in the function of the endothelium following exercise training may 
be the reason behind the increased arterial compliance identified in this research (Parnell, Holst & 
Kaye, 2002). 
 
Some of the studies included in this review reported a significant but limited improvement in FMD 
within the exercising extremity. The study by Kobayashi et al. (2003) showed that lower-limb 
dominant exercise training improved FMD in the lower limb but not in the untrained upper limb. 
Although this study reported significant improvement in EF, vasoconstritive substances and pro-
inflammatory humoral factors were left unaltered, raising a high index of suspicion that the reduction 
in humoral factors such as norepinephrine, endothelin-1 and interleukin-6 may not be the primary 
pathway of correction of endothelial dysfunction post-exercise. Noris et al., (1995) has shown that 
lamina flow of blood in the human umbilical vein endothelial cells (HUVEC) induces the production 
of nitric oxide (NO) which is predominantly dependent on the local shear-stress effect. This laminar 
shear stress at 8 dyne/cm2 also up-regulates the level NO synthase mRNA. In essence, these outcome 
suggest that local blood flow is responsible for the production of vasodilation substance by the 
endothelial cells. Conversely, some other studies provide evidence to suggest that the effect of 
exercise training on the endothelium may not only be limited to the exercising extremity. Belardinelli, 
55 
 
Capestro, Misiani, Scipione & Georgiou (2005) documented significant improvement in endothelium-
dependent vasomotor response of brachial artery following a leg exercise (bicycle ergometry); 
endothelial function improved irrespective of the NYHA functional class of the participants showing 
the effectiveness of exercise in correcting endothelial dysfunction in HF patients. It is considered that 
exercise-induced shear stress activates endothelium derived NO synthase with a consequent 
production in NO and other vasoactive compounds like bradykinin and prostacyclin which tends to 
improve the vasodilatation properties of the endothelium. In a related study, handgrip exercise showed 
to have a positive effect on the FMD; however this was only restricted to the exercising forearm, but 
when bicycle ergometer was used, a systemic cardiovascular effect was observed; indicating that 
systemic effect is likely when more muscle mass are engaged (Linke et al. 2001; Anagnostakou et al. 
2011). Although it is expected that the greatest increase in pulsatile blood flow should be in the 
vessels within the exercising muscle, the rise in blood pressure (BP) and heart rate (HR) during 
exercise increases pulsatile flow in the body systematically; therefore  giving rise to improved 
endothelial-dependent vasodilatation. The result is a vasodilatory response to Ach at the maximum 
concentration, to rise by 2.5 fold whereas FMD improved by 50% in HF (Linke et al 2001). Another 
study demonstrated a generalized vascular adaptation following a forearm resistance training. They 
argued that these benefits may not have resulted from just increase in blood flow but also by altering 
vital haemodynamic parameters (Maiorana et al. 2000). These outcomes, however, stands in 
contradiction to a previous research which failed to show similar result. Research conducted by 
Demopoulos et al. (1997) did not show any significant improvement in endothelial function of the 
untrained extremity following bicycle ergometer training. However, several explanation has been put 
forward as reasons for the disparity. Firstly, exercise were conducted at a significantly low intensity 
which could not raise the blood pressure amplitude to a level that could create a significant systemic 
effect. Secondly, the participants in Demopoulos et al. study were in the advanced stage of their heart 
condition. Moreover, their FMD were accessed using forearm venous occlusion plethysmography 
while other studies that showed systemic effect used high resolution ultrasound. Therefore the 
difference in outcome might have been due to the difference in the methodologic approach.  
 Another study which examined the impact of exercise on sexual dysfunction showed that 
improvement in the endothelium-dependent vasodilatation is the strongest independent predictor of 
sexual activity improvement in men with CHF. The result of the study demonstrates that exercise at a 
moderate intensity on bicycle ergometer improves endothelium-dependent vasorelaxation of a conduit 
vessel located in a part of the body that is not directly exercised. This seems to agree with evidence 
from previous studies suggesting a systemic benefit from a leg exercise (Belardinelli, Lacalaprice, 
Faccenda, Purcaro & Perna, 2005; Selig et al. 2004; Vona et al. 2004).    
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 Wisloff et al. (2007) showed greater improvement in brachial artery FMD in aerobic interval training 
compared to moderate continuous training in CHF. The investigators used high intensity aerobic 
interval training consisting of 4 minutes intervals at 90% to 95% of HRmax separated by 3 minutes of 
active pauses walking at 50% to 70% HRmax. However, combination of both interval training and 
strength training has shown to be more significant in terms of improvement in vascular reactivity. It is 
suggested that this outcome could be as a result of the different protocol applied by this study – a high 
intensity stimulus together with a higher exercise duration interval and a longer recovery period may 
be the main reason for the achieved outcome (Anagnostakou et al. 2011).  
  
 
 
13.2 EFFECT OF COMBINED versus AEROBIC TRAINING ON NO PRODUCTION 
 
Physiologically, the vascular endothelium produces vasoactive compounds such as NO, prostacyclin 
and bradykinin- which contribute to maintain the patency of the conduit vessels with the aim of 
ensuring proper flow of blood with a non-adherent endothelial surface (Lima de Melo Ghisi, Durieux, 
Pinho & Benetti, 2000). A decrease in NO bioavailability often result from reduced expression of 
endothelial cell NO synthase (eNOS), absence of cofactors or substrates for eNOS, poor activation of 
eNOS due to signalling problem with endothelial cells and increased production of reactive oxygen 
species (ROS) which degrades NO (Cai & Harrison, 2000).  There is a large body of evidence linking 
the reduction in NO bioavailability as the main underlying causative factor in endothelial vascular 
dysregulation.  Shear stress has been pointed out as the most effective physiological stimulant for 
eNOS gene expression and NO availability. In severe chronic heart failure (CHF) there is a decrease 
in endothelium derived NO and endothelium-dependent vasodilatation as a result of reduced ejection 
fraction (EF) and peripheral blood flow causing less shear stress to be exerted on the inner surface of 
the vascular endothelium (Bauersach & Widder, 2008).  However, Green et al. (2004) indicated that a 
combination of aerobic and resistance training improves endothelium-dependent NO-mediated 
vascular function to a greater extent. This is supported by another study which showed that 
performing aerobic exercise after resistance training resulted in a significance increase in FMD 
whereas aerobic exercise performed before RT did not significantly improve FMD (Okamoto, 
Masuhara, & Ikuta, 2007). Evidence from the current review suggest that combined exercise as 
opposed to only aerobic training appears to be more beneficial to HF patients but to how extent this is 
true is still subject to further investigation. 
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14.0 LIMITATIONS TO STUDY  
 
 
One of the major limitation to these study is that majority of the participants were predominantly male 
and so the result may be equivocal on its outcome especially when considering how the female 
counterparts actually gained from these trainings under review. Furthermore, the failure of two of the 
studies (Sandi et al. 2015; Kitzman et al. 2013) which had a total of 183 persons (nearly one in three 
of all participants), to report clearly the gender of its participants, unfortunately leaves the results at 
the mercy of ambiguity. Another observable flaw to these studies is that none of the research papers 
provided clear evidence on the sustainability of the improvement in the endothelial function gained 
after exercise. Raising further speculations on the need to further investigate the long term (12 months 
or more) outcomes after exercise in HF. Finally, out of the 14 studies included only 2 studies applied 
resistance training and the reason for this is still unclear.  Could it be that the participants were better 
motivated to undertake aerobic exercise or were they just being cautious in avoiding resistance 
exercises? 
      
 
15.0 CONCLUSION 
 
The outcome of this review suggest that different modes of exercise (aerobic, resistance or combined) 
have significant effect on the FMD. This however depends on the intensity of the exercise program. 
The most appropriate range may be difficult to determine since HF does not occur in isolation, it is 
imperative then that the vascular impact of the other co-morbidities be considered also during exercise 
programming thereby making the likelihood of a universal protocol almost impossible. However, 
most of the studies that yielded significant outcome performed aerobic exercise at a moderate 
intensity, although greater outcome were recorded when performed in combination with resistance 
training and at a higher intensity. 
A study has confirmed that vascular endothelial functions are impaired in HFPEF (Marechaux et al. 
2015). However, results from this review suggest that the improvement in EF occurred mostly with 
studies done among HFREF, with one study done among HFPEF showing no significant difference, 
therefore raising a high index of need to further explore the relevance of exercise on the endothelial 
function especially among HFPEF.  
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17.0 APPENDIX  
 
Table 9.          JADAD SCALE FOR THE POTENTIALLY INCLUDED STUDIES  
 
STUDY Was the 
study 
described as 
randomised? 
Was the 
study 
described 
as double 
blinded? 
Was there a 
description 
of 
withdrawals 
and 
dropouts? 
Was the 
randomization 
described as 
appropriate? 
Was the 
blinding 
described as 
appropriate? 
Jadad 
score 
Hornig, Maier & 
Drexler, 1996 
       --     --                       +         --          -- 1/5 
Ozasa, 
Morimoto,Bao,Shio& 
Kimura, 2012  
     
       +                         
 
   -- 
 
      + 
 
         + 
 
        -- 
 
3/5 
Kobayashi et al. 2003         + 
 
    --       +          +          -- 3/5 
Belardinelli et al. 
2005  
        + 
      
    --        +          +         -- 3/5 
Bellardinelli et al. 
2004  
        +     
         
    --        +          +         -- 3/5 
Linke et al. 2001          + 
         
    --        +          +         -- 3/5 
Hambrecht et al. 
2000  
        + 
         
    --        +          +         -- 3/5 
Selig et al. 2004         + 
         
    --        +          +         -- 3/5 
Anagnostakou et al. 
2011  
        +   
 
    --        +          +         -- 3/5 
Erbs et al. 2010          + 
         
    --        +          +         -- 3/5 
Hambrecht et al. 
1998  
        + 
         
    --        +          +         -- 3/5 
 Wisloff et al. 2007          + 
         
    --        +          +         -- 3/5 
Sandi et al. 2015         + 
         
    --        +          +         -- 3/5 
Kitzman et al. 2013         + 
         
    --        +          +         -- 3/5 
Parnell et al. 2002         +  
         
    --        +          +         -- 3/5  
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